PharmaCann
PrivateLast Round
Series D
Mar 27, 2024
Est. Valuation
$1.05B
Total Funding Raised
$157.69M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PharmaCann is a cannabis company that cultivates, processes, and dispenses high-quality medicinal cannabis products while developing innovative cannabinoid-based treatments to enhance the well-being of both adult and pediatric patients.
Sector
Consumer & Commerce
Verticals
D2C Brands, Pharma Supply Chain, Retail Technology
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PharmaCann Comparables
Compare PharmaCann with similar companies based on industry and business-model similarity.
PharmaCann Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 27, 2024 | ||||
| Series C | Apr 5, 2023 | ||||
| Debt | Jan 20, 2022 | ||||
| Debt | Jun 25, 2021 | ||||
| VC Round | Oct 16, 2020 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 72% MoM.
- Apr 17, 2026
Operates in eight states across the US.
Recent news
Latest coverage and updates
- sells_assets_toAug 25, 2026
PharmaCann, Inc. sold assets to Grown Rogue International in the amount of $4.5M on Aug 21st '26.
- receives_financingAug 21, 2026
PharmaCann, Inc. receives financing of $9M.
PharmaCann Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access